Search Results 551-560 of 18405 for prostate cancer
Prostate cancer: Does PSA level affect prognosis? Prostate-specific antigen (PSA) is a protein made by prostate tissue. Men with prostate cancer often have ...
"The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says Dr. Eugene Kwon, a Mayo Clinic urologist. Dr. Kwon says, ...
Biochemically Recurrent Prostate Cancer Detection With Integration of PSMA PET imaging and Extracellular Vesicle-Based Tumor Monitoring · Overview · Participation ...
Derek J. Lomas, M.D., is a urologist at Mayo Clinic who specializes in prostate cancer and studies focal therapy and advanced imaging such as PSMA PET to ...
About this study. This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 ...
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
New Mayo Clinic study advances personalized prostate cancer education with an EHR-integrated AI agent. Learn more.
Clinical Trials · A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer · More about research at Mayo ...
Other healthcare professionals, as needed. Mayo Clinic doctors are highly skilled in all aspects of prostate cancer care and across every specialty involved in ...
Prostate cancer. Doctors and departments ... Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.